SIX •
Healthcare •
Drug Manufacturers - General •
Quote as of 07/29/2026 15:30
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeSIX
Market Capitalization1,182.01 mln
Float8.69 mln
Earnings Date07/23/2026
Piotroski F-Score
2
/ 9
Weak
Beneish M-Score
-4.54
Highly reliable
1-Year Forecast
130
Transformational upside
Relative Strength
21
/ 100
Significantly lagging
Debt / Equity
0.01
Debt-free
ROE
-1.26
Negative
Business Description
Founded in Dublin in 1997, Cosmo N.V. is an Ireland-based life sciences company that creates and produces medical treatments and technology for digestive health, skin conditions, and related fields across global markets. Its current lineup includes products that help detect and treat colon abnormalities, manage inflammatory bowel conditions, address acne, and combat traveler's diarrhea, alongside an AI-powered endoscopy tool that helps doctors spot colorectal lesions in real time. The company is also advancing several treatments through clinical trials, targeting conditions such as ulcerative colitis, bile acid diarrhea, male pattern hair loss, and certain solid tumor cancers.